How to Buy Arcutis Biotherapeutics Stock

Arcutis Biotherapeutics Inc

Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases.

Arcutis Biotherapeutics stock last closed at $23.90, up 1.01% from the previous day, and has increased 47.44% in one year. It has overperformed other stocks in the Biotechnology industry by 0.6 percentage points. Arcutis Biotherapeutics stock is currently +44.24% from its 52-week low of $16.57, and -24.77% from its 52-week high of $31.77.

At the moment, there are 125.69M ARQT shares outstanding. The market value of ARQT is $3.00B. In the last 24 hours, 1.62M ARQT shares were traded.

How to Buy Arcutis Biotherapeutics Stock

Not sure how to invest in Arcutis Biotherapeutics stock? Here's how.

  1. Choose where to buy Arcutis Biotherapeutics stock: You need to pick a stock brokerage, but don't worry - we've tested dozens of stock brokerages and apps to help you choose where to buy Arcutis Biotherapeutics stock.
  2. Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
  3. Deposit money your investment account: Select your method of payment and add your details.
  4. Analyze Arcutis Biotherapeutics stock: The Arcutis Biotherapeutics ticker symbol is ARQT. Is Arcutis Biotherapeutics stock a good investment? Should you buy shares of ARQT? How do ARQT's underlying business fundamentals look? Do top analysts think Arcutis Biotherapeutics is a good buy? Why has ARQT's stock price moved recently? (Hint: Our stock market analysis website can help you figure out if ARQT is a good stock to buy).
  5. Place your ARQT trade: Decide if you will purchase ARQT shares at the current market price or use a limit order to purchase ARQT shares at a specific price.
  6. Watch your investment in ARQT: Create a watchlist to monitor your new investment in Arcutis Biotherapeutics stock.

Step 1: Choose where to buy Arcutis Biotherapeutics stock

You need a brokerage account in order to access the NASDAQ market and buy ARQT stock.

A brokerage account enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

We believe that eToro is the best stock brokerage. eToro gives you:

  • Invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you don't have the money to buy a full share, you can still buy the stock.
  • Access to global financial markets: From Tech to Energy, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Open your brokerage account

Now that you've chosen the best brokerage, the next step is to fill out some personal info so you can invest in ARQT today.

How to Start a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal data to open a new trading account.
  1. Submit your information by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit money your investment account

Now that you have filled out your info on the best stock market app for beginners, you need to deposit funds:

Check out this video walkthrough to see the process of depositing funds into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Analyze Arcutis Biotherapeutics stock

After you have identified the best place to buy Arcutis Biotherapeutics stock, it's very important to evaluate their stock prior to investing, so you truly comprehend the risk and opportunity.

Arcutis Biotherapeutics stock data

ARQT Price
$23.90
1w %
0.5%
1y %
47.44%
5y %
16.02%
P/E
113.81x
P/B
13.62x
P/S
6.72x
PEG
0.98x
Revenue
$463.98M
Earnings
$28.52M
Fore. Rev. Growth
22.15%
Fore. Earn. Growth
116.23%
Market Cap
$3.00B
Next Earnings
Oct 27, 2026
Next Dividend
N/A

Arcutis Biotherapeutics Overview

WallStreetZen was designed to help average investors perform more accurate fundamental analysis in minutes instead of hours.

You can see all of the due diligence checks on ARQT's stock page.

Is ARQT stock overvalued?

Analysts use a variety of different financial metrics, analyses, models, and charts to gauge ARQT's true value.

Using relative valuations methods:

  • ARQT may be overvalued based on its P/E ratio of 113.81x, relative to Biotechnology industry P/E ratio of 10.75x
  • ARQT may be overvalued based on its P/B ratio of 13.62x, relative to Biotechnology industry P/B ratio of 5.56x
  • ARQT could be undervalued based on its PEG ratio of 0.98x

You can access more valuation analysis on ARQT's stock here.

Is ARQT a healthy company?

Positive Health Checks:

  • There are more short-term assets than long-term liabilities on the ARQT balance sheet.
  • ARQT profit margin has gone up from -35.4% to 6.1% in the past year.
  • ARQT's operating cash flow of $39.31M allows it to safely service it's debt of $114.14M.
  • There are more short-term assets than short-term liabilities on the ARQT balance sheet.

Negative Health Checks:

  • ARQT earnings of $43.14M is not sufficient to cover its interest payments.
  • Total ARQT debt is higher than 5 years ago, relative to shareholder equity.
  • ARQT has a relatively high debt to equity ratio of 1.22.

Is it a good time to buy Arcutis Biotherapeutics stock, according to analysts?

Out of 3 Equities analysts who give forecasts on ARQT, the consensus analyst rating on Arcutis Biotherapeutics is a Strong Buy

Please note that analyst ratings are not stock recommendations, nor are they financial advice.

You can dive deeper into what analysts are forecasting on the Arcutis Biotherapeutics stock forecast page.

ARQT Technical Indicators

SMA10
24.26
SMA20
25.1
SMA50
26.37
SMA100
24.66
SMA200
25.6
MACD
-0.73
MACD Signal
-0.59
MACD Histogram
-0.14
RSI
38.13
Stochastic %K
14.91
Stochastic %D
14.94
StochRSI %K
11.13
StochRSI %D
8.44

ARQT Growth Numbers

Last year, ARQT revenue was $463.98M. In the last three year, ARQT's revenue has increased by 338.55% per year. This was faster than the Biotechnology industry average of 23.65%.

Dive into ARQT's earnings and revenue performance here.

Who is buying/selling ARQT?

In the last year, insiders at ARQT have sold more shares than they have bought.

Terrie Curran, Director of ARQT, was the latest ARQT insider to buy. They bought $83,721.48 worth of ARQT shares on Aug 27, 2026.

Learn more about who owns ARQT stock here.

Does ARQT provide a stable income stream?

No, Arcutis Biotherapeutics doesn't provide an income stream by paying out dividends.

ARQT Social Trading Data

One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to see what other traders have to say.

Step 5: Place your ARQT trade

You have two primary types of orders:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are usually fine.
  • Limit order: A limit order enables you to buy or sell a stock at a specific price (or better).
    If you want to be sure you're buying or selling at a given dollar amount limit, use a limit order.

Hit the Open button and eToro will place the order.

If you require additional help buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Watch your investment in ARQT

Now that you own some ARQT stock, you'll want to keep up with your company.

Create a watchlist to keep tabs on your ARQT stock.

ARQT Feed

How to Buy Stock in Arcutis Biotherapeutics

To summarize, here are the 6 steps to buy Arcutis Biotherapeutics stock:

  1. Choose where to buy Arcutis Biotherapeutics stock
  2. Open your brokerage account
  3. Deposit money your investment account
  4. Analyze Arcutis Biotherapeutics stock
  5. Place your ARQT trade
  6. Watch your investment in ARQT

If you are looking for a brokerage account, eToro is our recommended option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to watch your new investment in Arcutis Biotherapeutics, get started below.

NASDAQ: ARQT
$23.90+0.24 (+1.01%)
Updated Sep 4, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: ARQT
$23.90+0.24 (+1.01%)
Updated Sep 4, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Arcutis Biotherapeutics share?

As of Sep 4, 2026, it costs $23.90 to buy one share of Arcutis Biotherapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.418 shares of ARQT.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Arcutis Biotherapeutics stock?

According to 3 Wall Street analysts who monitor Arcutis Biotherapeutics, their consensus recommendation is to buy Arcutis Biotherapeutics stock.

What is the best way to buy Arcutis Biotherapeutics stock?

One way to place an order for Arcutis Biotherapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.